
Sorafenib (as Tosylate) is a compounded formulation containing sorafenib (as tosylate), prepared by Mixlab for veterinary use. Available by prescription.
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Sorafenib tosylate is a multi-kinase inhibitor utilized in veterinary medicine for its antineoplastic properties. It is a prescription medication available for use in dogs and cats, requiring professional guidance and monitoring by a licensed veterinarian. It is frequently considered in the context of oncology for patients presented with specific types of solid tumors or carcinomas.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is used in the context of managing cell signaling by blocking various tyrosine kinase receptors involved in tumor growth and blood vessel formation. Commonly observed effects include localized digestive changes such as vomiting, diarrhea or a decrease in appetite and behavioral shifts like lethargy. Because it can influence multiple organ systems, your veterinarian will monitor for observational signs of renal and hepatic status through regular blood tests. Owners should monitor for pale gums or unusual bruising and contact their veterinarian promptly.
Yes. Sorafenib is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before any medication is prepared.
Yes. Mixlab specializes in compounding sorafenib into customized strengths and flavored oral formats, such as capsules or oral liquids, to suit the specific needs of your pet.
Veterinarians discuss sorafenib because it inhibits the signals that tell certain cancer cells to divide and multiply. This offers an approach to managing the progression of specific oncological challenges.
Because sorafenib is a chemotherapy agent, your veterinarian will recommend wearing gloves when handling the medication. This offers an approach to preventing accidental absorption during the management course.
Your veterinarian will recommend frequent blood work, including a complete blood count (CBC) and liver enzymes. This monitoring ensures the management approach remains safe for your pet's health status.